Digital Health – From Cyberthreat to Health Equity

During his research seminar, Dr. Perakslis will discuss: -How healthcare continues to be digitized within a backdrop of cyberthreats-and that while many digital health technologies are essential innovations, others range from merely recreational to outright charlatanism. -How important it is to evaluate the benefits and risks of digital healthcare toolsets for their effects on people's safety and ambient privacy, and whether these effects are social, economic, traditional, or physical. -How digital health deployment can exacerbate inequities but mitigate some. -How researchers can protect themselves and their research subjects during open cyberwar should it arrive. Zoom Info: https://duke.zoom.us/j/99138887249 ID: 991 3888 7249 Speaker Bio Eric Perakslis, PhD, is Chief Science and Digital Officer at the Duke Clinical Research Institute, Professor of Population Health Sciences and Chief Research Technology Strategist, both at the Duke University School of Medicine. Recently, he was a Rubenstein Fellow at Duke University focused on collaborative efforts spanning medicine, policy, engineering, information technology, and security. Before arriving at Duke, Dr. Perakslis served as CSO at Datavant, Lecturer in the Department of Biomedical Informatics at Harvard Medical School, and Strategic Innovation Advisor to Médecins Sans Frontières. Previously, Dr. Perakslis was Senior Vice President and Head of Takeda R&D Data Science Institute, where he integrated all aspects of biopharmaceutical R&D and digital health. Before Takeda, he was Executive Director of the Center for Biomedical Informatics at the Countway Library of Medicine, instructor in pediatrics at Harvard Medical School (HMS), and faculty member at the Children's Hospital Informatics Program at Boston Children's Hospital. Prior to HMS, Dr. Perakslis served as Chief Information Officer and Chief Scientist (Informatics) at the U.S. Food and Drug Administration. In this role, he authored the first IT Strategic Plan for the FDA and was responsible for modernizing and enhancing their IT and in silico capabilities. Dr. Perakslis was also Senior Vice President of R&D Information Technology at Johnson & Johnson Pharmaceuticals and a member of the Corporate Office of Science and Technology before his position at the FDA. While at J&J, Dr. Perakslis created tranSMART, an open-sourced clinical data system, which is now freely used by hundreds of healthcare organizations.